John Lacy Iii Provectus Biopharmaceuticals, Inc. (PVCT) insider trading activity
John Lacy Iii is Director of PROVECTUS BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 200,000 shares of PVCT, which is worth approximately $26,000. The most recent transaction as insider was on Nov 10, 2020, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
200K
0%
3M change
0%
12M change
Total Value Held
$26,000
JLI
John Lacy Iii
Director
Knoxville, TN